Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
500257 | BSE
-10.50
-0.84%
Other
Other
31/03/2023
08/12/2023
1,238.20
1,262.60
1,262.60
1,231.00
Lupin Limited a pharmaceutical company develops produces and markets a range of branded and generic formulations biotechnology products and active pharmaceutical ingredients (APIs) worldwide. It offers formulations for use in the therapeutic areas of cardiovascular diabetology asthama pediatrics central nervous system (CNS) gastro-intestinal anti-infectives nonsteroidal anti inflammatory drug therapy anti-TB and cephalosporins. The company also develops drug delivery technologies; and offers biosimilars for various therapies such as oncology anti-inflammatory anti-virals rheumatoid arthritis endocrinology diabetes ophthalmology and women?s health. In addition it engages in the novel drug discovery and development programs for use in the treatment of CNS disorders oncology immunology pain and metabolic disorders. The company was formerly known as Lupin Chemicals Limited and changed its name to Lupin Limited in 2001 as a result of its amalgamation with Lupin Laboratories Limited. Lupin Limited was founded in 1968 and is based in Mumbai India.
View LessLow 6-Month Volatility (<30%)
Value Stock (Price to Book < 3)
Strong Sharpe Ratio (> 1.2)
Weakness based on declining price with high volume
Price Below SMA10D
High Short-term Volatility
High Current Volume and Negative 1-Day Return
Midcap (2B - 10B USD)
No Dividends (Dividend Yield = 0%)
High Debt to Equity (> 0.75)
High Debt to Asset (> 0.45)
Weak Operating Margin (< 10%)
Bullish: Stable Volatility (6-month <= 1-month volatility) is positive for the stock performance.
10 days
29.9%1 month
25.7%3 months
22.7%6 months
23.6%0
0
0
0.84
0.46
0
0
0
0
498.07B
5.97B
0
0
0
0
349.41
0
0
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bullish (SMA1M > SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
Range10D
106.70
Range1M
166.35
Range3M
228.10
Rel. volume
3.02
Price X volume
318.80M